Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy evaluation of two commercial modified-live virus vaccines against a novel recombinant type 2 porcine reproductive and respiratory syndrome virus

12 Feb 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to Viral gastroenteritis research and epidemiology
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29519513
DOI: 10.1016/j.vetmic.2018.02.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy evaluation of two commercial modified-live virus vaccines against a novel recombinant type 2 porcine reproductive and respiratory syndrome virusPMID 29519513Read ↗

Live porcine reproductive and respiratory syndrome virus vaccines: Current status and future directionSemantic proximity Read ↗

Commercial PRRS Modified-Live Virus VaccinesSemantic proximity Read ↗

A recombinant porcine reproductive and respiratory syndrome virus type 2 field strain derived from two PRRSV-2-modified live virus vaccinesSemantic proximity Read ↗

Novel strategies and approaches to develop the next generation of vaccines against porcine reproductive and respiratory syndrome virus (PRRSV)Semantic proximity Read ↗

Inactivated and subunit vaccines against porcine reproductive and respiratory syndrome: Current status and future directionSemantic proximity Read ↗

Research Progress on the Development of Porcine Reproductive and Respiratory Syndrome VaccinesSemantic proximity Read ↗

Current Status of Porcine Reproductive and Respiratory Syndrome VaccinesSemantic proximity Read ↗

Evaluation of a 20 year old porcine reproductive and respiratory syndrome (PRRS) modified live vaccine (Ingelvac ® PRRS MLV) against two recent type 2 PRRS virus isolates in South KoreaSemantic proximity Read ↗

An attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) protects piglets against HP-PRRSSemantic proximity Read ↗

Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challengeSemantic proximity Read ↗

Two natural recombinant highly pathogenic porcine reproductive and respiratory syndrome viruses with different pathogenicitiesSemantic proximity Read ↗

Porcine Reproductive and Respiratory Syndrome Modified Live Virus Vaccine: A “Leaky” Vaccine with Debatable Efficacy and SafetySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.